Bids Are Invited For Price Registration For Future And Possible Acquisitions Of Digestive Medicines Part 1 - Annual Plan 2025, Aiming To Meet The Needs Of The Bodies And Entities Of The State Of Sergipe.

Ascorbic Acid - Concentration/Dosage 100 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 5 Ml, Intravenous Administration Route, Ursodeoxycolic Acid - Concentration/Dosage 50 Mg, Tablet Pharmaceutical Form, Oral Administration Route, Amino Acids - 10 % (100Mg/Ml), Polyaminoacid, Solution, Bottle With 100Ml, Infusion, Atropine, Sulfate - Concentration/Dosage 0.25 Mg/Ml, Pharmaceutical Form Injectable Solution, Presentation Form Ampoule With 1Ml, Intravenous Administration Route, Sodium Bicarbonate - Pharmaceutical Form Injectable Solution, Concentration/Dosage 8.4%, 10Ml Ampoule Presentation Form, 01/08/2025, Bisacodyl - Concentration/Dosage 5 Mg, Tablet Or Dragee Pharmaceutical Form, Bromopride - Concentration/Dosage 5 Mg/Ml, Ampoule Presentation Form With 2Ml, Via For Intravenous Or Intramuscular Administration, Cimetidine - Concentration/Dosage 200 Mg, Oral Administration Route, Potassium Chloride - In Adult And Pediatric Injectable Solution 19.1%, Injectable Solution, 10Ml, Potassium Chloride - 10%, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 10Ml, The Packaging Must Be Externally Identification Data, Batch Number, Manufacturing Date And Expiration Date. At The Delivery Date, The Product Must Have At Least 75% Of Its Total Expiration Date. According To Ordinance 2814 Gm/1998, The Product Must Present In Its Primary And/Or Secondary Packaging, Potassium Chloride - Concentration/Dosage 60 Mg, Solution Pharmaceutical Form, Presentation Form Bottle With 100Ml, The Packaging Must Bear Identification Data Externally, Manufacturing Date And Expiration Date. On The Delivery Date, The Product Must Present In Its Primary And/Or Secondary Packaging, Sodium Chloride - Concentration/Dosage Of 20% In Ampoule With 10Ml, Dimenhydrinate + Pyridoxine - Concentration/Dosage 25 Mg/Ml + 5 Mg/Ml Respectively, Pharmaceutical Form Solution, Form Presentation Bottle With 20Ml, Route Of Administration Oral. The Packaging Must Have Identification Data On The Outside, Domperidone - Concentration/Dosage 1 Mg/Ml, Presentation Of Oral Suspension, Presentation Form Of Bottle With 100 Ml, The Packaging Must Have Identification Data On The Outside, The Product Must Have A Minimum Shelf Life., Scopolamine, Butylbromide - Concentration/Dosage 10 Mg/Ml, Pharmaceutical Form Oral Solution, Bottle Presentation Form, Butylbromide - Concentration/Dosage 10 Mg, Pharmaceutical Form, Tablet Or Dragee, Butylbromide - Concentration/Dosage 20 Mg/Ml, Intramuscular And Subcutaneous, Butylbromide + Sodium Dipyrone - Concentration/Dosage 4Mg/Ml+ 500 Mg /Ml Respectively, Presentation Form Ampoule With 5Ml, Butylbromide + Sodium Dipyrone - Concentration/Dosage 6.67 Mg/Ml + 333.4 Mg/Ml Respectively, Presentation Bottle With 20Ml, Manufacturing Date And Expiry Date. Product Must Present In Its Primary And/Or Secondary Packaging, Phosphate Of Potassium - Concentration/Dosage 2 Meq/Ml, Intravenous Administration Route. The Packaging Must Bear Identification Data Externally, Glibenclamide - Concentration/Dosage 5 Mg, Glycerol - Adult, In Suppository, Packed In Strip, Anal